ANL 13.55 Decreased By ▼ -0.79 (-5.51%)
ASC 13.32 Decreased By ▼ -0.63 (-4.52%)
ASL 14.02 Decreased By ▼ -1.08 (-7.15%)
BOP 8.36 Decreased By ▼ -0.16 (-1.88%)
BYCO 6.14 Decreased By ▼ -0.40 (-6.12%)
FCCL 17.61 Decreased By ▼ -1.19 (-6.33%)
FFBL 24.90 Decreased By ▼ -1.95 (-7.26%)
FFL 10.25 Decreased By ▼ -0.75 (-6.82%)
FNEL 9.80 Decreased By ▼ -0.71 (-6.76%)
GGGL 15.30 Decreased By ▼ -0.95 (-5.85%)
GGL 29.50 Decreased By ▼ -2.00 (-6.35%)
HUMNL 5.90 Decreased By ▼ -0.34 (-5.45%)
JSCL 16.00 Decreased By ▼ -0.89 (-5.27%)
KAPCO 32.05 Decreased By ▼ -1.05 (-3.17%)
KEL 3.17 Decreased By ▼ -0.10 (-3.06%)
MDTL 2.21 Decreased By ▼ -0.06 (-2.64%)
MLCF 34.39 Decreased By ▼ -2.71 (-7.3%)
NETSOL 95.50 Decreased By ▼ -7.30 (-7.1%)
PACE 4.25 Decreased By ▼ -0.43 (-9.19%)
PAEL 21.43 Decreased By ▼ -1.72 (-7.43%)
PIBTL 7.60 Decreased By ▼ -0.26 (-3.31%)
POWER 6.60 Decreased By ▼ -0.45 (-6.38%)
PRL 12.69 Decreased By ▼ -0.97 (-7.1%)
PTC 8.75 Decreased By ▼ -0.15 (-1.69%)
SILK 1.25 Decreased By ▼ -0.06 (-4.58%)
SNGP 38.68 Decreased By ▼ -3.02 (-7.24%)
TELE 15.88 Decreased By ▼ -1.11 (-6.53%)
TRG 81.73 Decreased By ▼ -6.02 (-6.86%)
UNITY 23.70 Decreased By ▼ -1.65 (-6.51%)
WTL 2.05 Decreased By ▼ -0.15 (-6.82%)
BR100 4,401 Decreased By ▼ -269.99 (-5.78%)
BR30 17,494 Decreased By ▼ -1340.29 (-7.12%)
KSE100 43,150 Decreased By ▼ -2219.38 (-4.89%)
KSE30 16,664 Decreased By ▼ -912.27 (-5.19%)

Coronavirus
LOW Source: covid.gov.pk
Pakistan Deaths
28,745
824hr
Pakistan Cases
1,285,631
37724hr
0.85% positivity
Sindh
476,017
Punjab
443,240
Balochistan
33,488
Islamabad
107,765
KPK
180,146
World

Pfizer, Moderna COVID vaccines appear effective against Indian variants: Research

  • As per lab experiments involving cell cultures, the B.1.617 and B.1.618 variants seem to be partially resistant to the antibodies developed by the vaccination
  • Researchers say the vaccine's antibodies are a little bit weaker against the variants, but not to an extent that it would have much of an effect on the protective ability of the vaccines
Updated 18 May 2021

(Karachi) The coronavirus vaccines developed by biotechnology giants, Pfizer and Moderna, appear to protect against triple-mutant coronavirus variants from India, B.1.617 and B.1.618, researchers have revealed.

The recent study has been carried out by the New York University Grossman School of Medicine and NYU Langone Center and is considered preliminary because it has not yet been published in a peer-reviewed journal.

As per lab experiments involving cell cultures, the B.1.617 and B.1.618 variants seem to be partially resistant to the antibodies developed by the vaccination.

Researchers said that there is a good reason to believe that vaccinated individuals will remain protected against the B.1.617 and B.1.618 variants.

They added that the vaccine's antibodies are a little bit weaker against the variants, but not to an extent that it would have much of an effect on the protective ability of the vaccines.

Earlier, the World Health Organization reclassified the highly contagious triple-mutant Covid variant spreading in India as a “variant of concern,” indicating that it’s become a global health threat.

WHO's Technical Lead for COVID-19, Maria Van Kerkhove said the variant, known as B.1.617, has been found in preliminary studies to spread more easily than the original virus and there is some evidence it may able to evade some of the protections provided by vaccines.

“And as such we are classifying this as a variant of concern at the global level,” she said.

Kerkhove stated, “Even though there is increased transmissibility demonstrated by some preliminary studies, we need much more information about this virus variant in this lineage in all of the sub-lineages, so we need more sequencing, targeted sequencing to be done.”

We love hearing your feedback, please help us improve by answering these few survey questions

Comments

Comments are closed.